Global Pet Veterinary Drug Sales Market Report 2021

Publisher Name :
Date: 08-Jun-2021
No. of pages: 136
Inquire Before Buying

The global Pet Veterinary Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Anti-Infectives

- Anti-Inflammatory

- Parasiticides

- Analgesics

- Sedatives

- Others

Segment by Application

- Veterinary Hospitals

- Veterinary Clinics

- Drug Stores

The Pet Veterinary Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Pet Veterinary Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Boehringer Ingelheim International GmbH

- Zoetis Animal Healthcare

- Bayer AG

- Merck Animal Health

- Elanco Animal Health Inc.

- Virbac Group

- Ceva

- Dechra Pharmaceuticals Plc

- Vetoquinol

- Orion Corporation

Global Pet Veterinary Drug Sales Market Report 2021

Table of Contents
1 Pet Veterinary Drug Market Overview
1.1 Pet Veterinary Drug Product Scope
1.2 Pet Veterinary Drug Segment by Type
1.2.1 Global Pet Veterinary Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Pet Veterinary Drug Segment by Application
1.3.1 Global Pet Veterinary Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 Pet Veterinary Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pet Veterinary Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pet Veterinary Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pet Veterinary Drug Price Trends (2016-2027)
2 Pet Veterinary Drug Estimates and Forecasts by Region
2.1 Global Pet Veterinary Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pet Veterinary Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pet Veterinary Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Pet Veterinary Drug Revenue Market Share by Region (2016-2021)
2.3 Global Pet Veterinary Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pet Veterinary Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pet Veterinary Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pet Veterinary Drug Estimates and Projections (2016-2027)
2.4.2 Europe Pet Veterinary Drug Estimates and Projections (2016-2027)
2.4.3 China Pet Veterinary Drug Estimates and Projections (2016-2027)
2.4.4 Japan Pet Veterinary Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pet Veterinary Drug Estimates and Projections (2016-2027)
2.4.6 India Pet Veterinary Drug Estimates and Projections (2016-2027)
3 Global Pet Veterinary Drug Competition Landscape by Players
3.1 Global Top Pet Veterinary Drug Players by Sales (2016-2021)
3.2 Global Top Pet Veterinary Drug Players by Revenue (2016-2021)
3.3 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Veterinary Drug as of 2020)
3.4 Global Pet Veterinary Drug Average Price by Company (2016-2021)
3.5 Manufacturers Pet Veterinary Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pet Veterinary Drug Market Size by Type
4.1 Global Pet Veterinary Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Pet Veterinary Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Pet Veterinary Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Pet Veterinary Drug Price by Type (2016-2021)
4.2 Global Pet Veterinary Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pet Veterinary Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Pet Veterinary Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Pet Veterinary Drug Price Forecast by Type (2022-2027)
5 Global Pet Veterinary Drug Market Size by Application
5.1 Global Pet Veterinary Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Pet Veterinary Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Pet Veterinary Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Pet Veterinary Drug Price by Application (2016-2021)
5.2 Global Pet Veterinary Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pet Veterinary Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Pet Veterinary Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Pet Veterinary Drug Price Forecast by Application (2022-2027)
6 North America Pet Veterinary Drug Market Facts & Figures
6.1 North America Pet Veterinary Drug Sales by Company
6.1.1 North America Pet Veterinary Drug Sales by Company (2016-2021)
6.1.2 North America Pet Veterinary Drug Revenue by Company (2016-2021)
6.2 North America Pet Veterinary Drug Sales Breakdown by Type
6.2.1 North America Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
6.3 North America Pet Veterinary Drug Sales Breakdown by Application
6.3.1 North America Pet Veterinary Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Pet Veterinary Drug Sales Breakdown by Application (2022-2027)
7 Europe Pet Veterinary Drug Market Facts & Figures
7.1 Europe Pet Veterinary Drug Sales by Company
7.1.1 Europe Pet Veterinary Drug Sales by Company (2016-2021)
7.1.2 Europe Pet Veterinary Drug Revenue by Company (2016-2021)
7.2 Europe Pet Veterinary Drug Sales Breakdown by Type
7.2.1 Europe Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Pet Veterinary Drug Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Pet Veterinary Drug Market Facts & Figures
8.1 China Pet Veterinary Drug Sales by Company
8.1.1 China Pet Veterinary Drug Sales by Company (2016-2021)
8.1.2 China Pet Veterinary Drug Revenue by Company (2016-2021)
8.2 China Pet Veterinary Drug Sales Breakdown by Type
8.2.1 China Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
8.3 China Pet Veterinary Drug Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Pet Veterinary Drug Market Facts & Figures
9.1 Japan Pet Veterinary Drug Sales by Company
9.1.1 Japan Pet Veterinary Drug Sales by Company (2016-2021)
9.1.2 Japan Pet Veterinary Drug Revenue by Company (2016-2021)
9.2 Japan Pet Veterinary Drug Sales Breakdown by Type
9.2.1 Japan Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Pet Veterinary Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pet Veterinary Drug Market Facts & Figures
10.1 Southeast Asia Pet Veterinary Drug Sales by Company
10.1.1 Southeast Asia Pet Veterinary Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Pet Veterinary Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Pet Veterinary Drug Sales Breakdown by Type
10.2.1 Southeast Asia Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pet Veterinary Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Pet Veterinary Drug Market Facts & Figures
11.1 India Pet Veterinary Drug Sales by Company
11.1.1 India Pet Veterinary Drug Sales by Company (2016-2021)
11.1.2 India Pet Veterinary Drug Revenue by Company (2016-2021)
11.2 India Pet Veterinary Drug Sales Breakdown by Type
11.2.1 India Pet Veterinary Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Pet Veterinary Drug Sales Breakdown by Type (2022-2027)
11.3 India Pet Veterinary Drug Sales Breakdown by Application
11.3.1 India Pet Veterinary Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Pet Veterinary Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pet Veterinary Drug Business
12.1 Boehringer Ingelheim International GmbH
12.1.1 Boehringer Ingelheim International GmbH Corporation Information
12.1.2 Boehringer Ingelheim International GmbH Business Overview
12.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
12.1.5 Boehringer Ingelheim International GmbH Recent Development
12.2 Zoetis Animal Healthcare
12.2.1 Zoetis Animal Healthcare Corporation Information
12.2.2 Zoetis Animal Healthcare Business Overview
12.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Products Offered
12.2.5 Zoetis Animal Healthcare Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Business Overview
12.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer AG Pet Veterinary Drug Products Offered
12.3.5 Bayer AG Recent Development
12.4 Merck Animal Health
12.4.1 Merck Animal Health Corporation Information
12.4.2 Merck Animal Health Business Overview
12.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Animal Health Pet Veterinary Drug Products Offered
12.4.5 Merck Animal Health Recent Development
12.5 Elanco Animal Health Inc.
12.5.1 Elanco Animal Health Inc. Corporation Information
12.5.2 Elanco Animal Health Inc. Business Overview
12.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Products Offered
12.5.5 Elanco Animal Health Inc. Recent Development
12.6 Virbac Group
12.6.1 Virbac Group Corporation Information
12.6.2 Virbac Group Business Overview
12.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Virbac Group Pet Veterinary Drug Products Offered
12.6.5 Virbac Group Recent Development
12.7 Ceva
12.7.1 Ceva Corporation Information
12.7.2 Ceva Business Overview
12.7.3 Ceva Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ceva Pet Veterinary Drug Products Offered
12.7.5 Ceva Recent Development
12.8 Dechra Pharmaceuticals Plc
12.8.1 Dechra Pharmaceuticals Plc Corporation Information
12.8.2 Dechra Pharmaceuticals Plc Business Overview
12.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Products Offered
12.8.5 Dechra Pharmaceuticals Plc Recent Development
12.9 Vetoquinol
12.9.1 Vetoquinol Corporation Information
12.9.2 Vetoquinol Business Overview
12.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Vetoquinol Pet Veterinary Drug Products Offered
12.9.5 Vetoquinol Recent Development
12.10 Orion Corporation
12.10.1 Orion Corporation Corporation Information
12.10.2 Orion Corporation Business Overview
12.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Orion Corporation Pet Veterinary Drug Products Offered
12.10.5 Orion Corporation Recent Development
13 Pet Veterinary Drug Manufacturing Cost Analysis
13.1 Pet Veterinary Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pet Veterinary Drug
13.4 Pet Veterinary Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pet Veterinary Drug Distributors List
14.3 Pet Veterinary Drug Customers
15 Market Dynamics
15.1 Pet Veterinary Drug Market Trends
15.2 Pet Veterinary Drug Drivers
15.3 Pet Veterinary Drug Market Challenges
15.4 Pet Veterinary Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Pet Veterinary Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Pet Veterinary Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Pet Veterinary Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Pet Veterinary Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Pet Veterinary Drug Sales Market Share by Region (2016-2021)
Table 6. Global Pet Veterinary Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Pet Veterinary Drug Revenue Share by Region (2016-2021)
Table 8. Global Pet Veterinary Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Pet Veterinary Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Pet Veterinary Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Pet Veterinary Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Pet Veterinary Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Pet Veterinary Drug Sales Share by Company (2016-2021)
Table 14. Global Pet Veterinary Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Pet Veterinary Drug Revenue Share by Company (2016-2021)
Table 16. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Veterinary Drug as of 2020)
Table 17. Global Pet Veterinary Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Pet Veterinary Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Pet Veterinary Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Pet Veterinary Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Pet Veterinary Drug Sales Share by Type (2016-2021)
Table 23. Global Pet Veterinary Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Pet Veterinary Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Pet Veterinary Drug Sales Share by Type (2022-2027)
Table 26. Global Pet Veterinary Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Pet Veterinary Drug Revenue Share by Type (2022-2027)
Table 28. Global Pet Veterinary Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Pet Veterinary Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Pet Veterinary Drug Sales Share by Application (2016-2021)
Table 31. Global Pet Veterinary Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Pet Veterinary Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Pet Veterinary Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Pet Veterinary Drug Sales Share by Application (2022-2027)
Table 35. Global Pet Veterinary Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Pet Veterinary Drug Revenue Share by Application (2022-2027)
Table 37. Global Pet Veterinary Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 40. North America Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 44. North America Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 46. North America Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 48. North America Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 62. China Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 63. China Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 64. China Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 66. China Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 68. China Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 70. China Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 72. China Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 98. India Pet Veterinary Drug Sales (K Units) by Company (2016-2021)
Table 99. India Pet Veterinary Drug Sales Market Share by Company (2016-2021)
Table 100. India Pet Veterinary Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Pet Veterinary Drug Revenue Market Share by Company (2016-2021)
Table 102. India Pet Veterinary Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Pet Veterinary Drug Sales Market Share by Type (2016-2021)
Table 104. India Pet Veterinary Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Pet Veterinary Drug Sales Market Share by Type (2022-2027)
Table 106. India Pet Veterinary Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Pet Veterinary Drug Sales Market Share by Application (2016-2021)
Table 108. India Pet Veterinary Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Pet Veterinary Drug Sales Market Share by Application (2022-2027)
Table 110. Boehringer Ingelheim International GmbH Corporation Information
Table 111. Boehringer Ingelheim International GmbH Description and Business Overview
Table 112. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product
Table 114. Boehringer Ingelheim International GmbH Recent Development
Table 115. Zoetis Animal Healthcare Corporation Information
Table 116. Zoetis Animal Healthcare Description and Business Overview
Table 117. Zoetis Animal Healthcare Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Zoetis Animal Healthcare Pet Veterinary Drug Product
Table 119. Zoetis Animal Healthcare Recent Development
Table 120. Bayer AG Corporation Information
Table 121. Bayer AG Description and Business Overview
Table 122. Bayer AG Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bayer AG Pet Veterinary Drug Product
Table 124. Bayer AG Recent Development
Table 125. Merck Animal Health Corporation Information
Table 126. Merck Animal Health Description and Business Overview
Table 127. Merck Animal Health Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck Animal Health Pet Veterinary Drug Product
Table 129. Merck Animal Health Recent Development
Table 130. Elanco Animal Health Inc. Corporation Information
Table 131. Elanco Animal Health Inc. Description and Business Overview
Table 132. Elanco Animal Health Inc. Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Elanco Animal Health Inc. Pet Veterinary Drug Product
Table 134. Elanco Animal Health Inc. Recent Development
Table 135. Virbac Group Corporation Information
Table 136. Virbac Group Description and Business Overview
Table 137. Virbac Group Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Virbac Group Pet Veterinary Drug Product
Table 139. Virbac Group Recent Development
Table 140. Ceva Corporation Information
Table 141. Ceva Description and Business Overview
Table 142. Ceva Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Ceva Pet Veterinary Drug Product
Table 144. Ceva Recent Development
Table 145. Dechra Pharmaceuticals Plc Corporation Information
Table 146. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Dechra Pharmaceuticals Plc Description and Business Overview
Table 148. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product
Table 149. Dechra Pharmaceuticals Plc Recent Development
Table 150. Vetoquinol Corporation Information
Table 151. Vetoquinol Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Vetoquinol Description and Business Overview
Table 153. Vetoquinol Pet Veterinary Drug Product
Table 154. Vetoquinol Recent Development
Table 155. Orion Corporation Corporation Information
Table 156. Orion Corporation Description and Business Overview
Table 157. Orion Corporation Pet Veterinary Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Orion Corporation Pet Veterinary Drug Product
Table 159. Orion Corporation Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Pet Veterinary Drug Distributors List
Table 163. Pet Veterinary Drug Customers List
Table 164. Pet Veterinary Drug Market Trends
Table 165. Pet Veterinary Drug Market Drivers
Table 166. Pet Veterinary Drug Market Challenges
Table 167. Pet Veterinary Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Veterinary Drug Product Picture
Figure 2. Global Pet Veterinary Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pet Veterinary Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Veterinary Hospitals Examples
Figure 7. Veterinary Clinics Examples
Figure 8. Drug Stores Examples
Figure 9. Global Pet Veterinary Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Pet Veterinary Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Pet Veterinary Drug Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Pet Veterinary Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Pet Veterinary Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Pet Veterinary Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Pet Veterinary Drug Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Pet Veterinary Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Pet Veterinary Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Pet Veterinary Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Pet Veterinary Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Pet Veterinary Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Pet Veterinary Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Pet Veterinary Drug Players Market Share by Revenue in Pet Veterinary Drug: 2016 & 2020
Figure 28. Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Pet Veterinary Drug Revenue Share by Type (2016-2021)
Figure 30. Global Pet Veterinary Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Pet Veterinary Drug Revenue Share by Application (2016-2021)
Figure 32. Global Pet Veterinary Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 34. North America Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 35. Europe Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 36. Europe Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 37. China Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 38. China Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 39. Japan Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 40. Japan Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 43. India Pet Veterinary Drug Sales Market Share by Type in 2020
Figure 44. India Pet Veterinary Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Pet Veterinary Drug
Figure 47. Manufacturing Process Analysis of Pet Veterinary Drug
Figure 48. Pet Veterinary Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs